18.77

0.16% 0.03

After Hours: 18.74 -0.03 -0.16%

Ceribell Inc (CBLL)

Overview News Price History Discussions Forecast

Ceribell Inc stock is traded at $18.77, with a volume of 204.30K. It is up +0.16% in the last 24 hours and down -12.00% over the past month. CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Previous Close:

$18.74

Open:

$18.8

24h Volume:

204.30K

Relative Volume:

0.65

Market Cap:

$712.18M

Revenue:

$89.06M

Net Income/Loss:

$-53.41M

P/E Ratio:

-12.85

EPS:

-1.4612

Net Cash Flow:

$-42.48M

1W Performance:

+15.15%

1M Performance:

-12.00%

6M Performance:

+23.00%

1Y Performance:

+8.75%

1-Day Range:

$18.68

$19.20

1-Week Range:

$16.30

$19.20

52-Week Range:

$10.85

$24.33

Ceribell Inc Stock (CBLL) Company Profile

Name

Ceribell Inc

Sector

Healthcare (1108)

Industry

Medical Devices (143)

Phone

(800) 436-0826

Address

360 N. PASTORIA AVENUE, SUNNYVALE

Employee

300

Twitter

Next Earnings Date

2026-05-11

Latest SEC Filings

CBLL's Discussions on Twitter

Compare CBLL vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CBLL Ceribell Inc	18.77	711.05M	89.06M	-53.41M	-42.48M	-1.4612
ABT Abbott Laboratories	87.41	152.88B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	316.48	120.18B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	78.60	100.34B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	57.78	84.95B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	85.78	47.91B	6.30B	1.07B	1.09B	1.8406

Ceribell Inc Stock (CBLL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-21-25	Initiated	Raymond James	Strong Buy
Jun-24-25	Initiated	BTIG Research	Buy
Apr-04-25	Initiated	Ladenburg Thalmann	Buy
Nov-05-24	Initiated	BofA Securities	Buy
Nov-05-24	Initiated	Canaccord Genuity	Buy
Nov-05-24	Initiated	JP Morgan	Overweight
Nov-05-24	Initiated	TD Cowen	Buy
Nov-05-24	Initiated	William Blair	Outperform

View All

Ceribell Inc Stock (CBLL) Latest News

May 20, 2026

Ceribell CEO to present at William Blair Growth Stock Conference on June 3, 2026 - Pluang

May 20, 2026

Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference - GlobeNewswire

May 20, 2026

May 18, 2026

Earnings call transcript: Ceribell Inc. Q1 2026 misses EPS, revenue up - Investing.com Nigeria

May 18, 2026

Bank of America Securities Remains a Buy on Ceribell, Inc. (CBLL) - The Globe and Mail

May 18, 2026

Canaccord Genuity maintains Ceribell (CBLL) buy recommendation - MSN

May 18, 2026

May 15, 2026

Ceribell anticipates $112M-$116M 2026 revenue while targeting delirium NTAP of up to $2,171 per patient - MSN

May 15, 2026

CBLL Stock Price, Quote & Chart | CERIBELL INC (NASDAQ:CBLL) - ChartMill

May 15, 2026

CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit Records - Yahoo Finance

May 15, 2026

May 14, 2026

Ladenburg Thalmann Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $32 - Moomoo

May 14, 2026

May 13, 2026

Middle East Tensions Threaten Ceribell’s Supply Chain, Shipping Routes, and Margins - TipRanks

May 13, 2026

May 12, 2026

Ceribell’s Earnings Call Signals Growth Over Profits - The Globe and Mail

May 12, 2026

TD Cowen Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $29 - Moomoo

May 12, 2026

A Quick Look at Today's Ratings for Ceribell(CBLL.US), With a Forecast Between $25 to $29 - Moomoo

May 12, 2026

Canaccord lowers Ceribell stock price target on valuation compression By Investing.com - Investing.com Australia

May 12, 2026

Canaccord lowers Ceribell stock price target on valuation compression - Investing.com

May 12, 2026

Ceribell: Buy Rating Reiterated on Strong Q1 Momentum and Expanded TAM, $28 Price Target Maintained - TipRanks

May 12, 2026

CeriBell Q1 Loss Widens, Revenue Rises; Lifts Full-Year Revenue Guidance - Moomoo

May 11, 2026

Ceribell Inc (NASDAQ:CBLL) Q1 Revenue Beats Estimates, Net Loss Widens, Full-Year Guidance Raised - ChartMill

May 11, 2026

CERIBELL ($CBLL) Releases Q1 2026 Earnings - Quiver Quantitative

May 11, 2026

Ceribell beats Q1 revenue estimates; lifts 2026 guidance - TradingView

May 11, 2026

(CBLL) CeriBell Now Expects 2026 Revenue Range $112M-$116M, vs. FactSet Est of $113.1M - marketscreener.com

May 11, 2026

Earnings Flash (CBLL) CeriBell Posts Q1 Per Share Loss $0.52, vs. FactSet Est of Loss $0.39 - marketscreener.com

May 11, 2026

Earnings Flash (CBLL) Ceribell, Inc. Reports Q1 Revenue $26.5M, vs. FactSet Est of $26.1M - marketscreener.com

May 11, 2026

Ceribell, Inc. Raises Revenue Guidance for the Full Year 2026 - marketscreener.com

May 11, 2026